Photo of Ann Wagner
R United States House · District 2 · Missouri On the 2026 ballot

Rep. Ann Wagner

Compare
Total votes
2,818
all sessions
Attendance
98%
53 missed
Near the chamber average
With party
93%
of cast votes
Near the chamber average
Bipartisan score
4%
crosses aisle rarely
Near the chamber average
Sponsored
664
bills & resolutions
Lower than 81% of chamber peers
Committees
6
assignments
664 bills and resolutions

Sponsored bills

Total
664
Primary
62
Co-sponsor
602
This page
664
matching current filters
Co-sponsor HRES 692
In committee · Utah House · Co-sponsor
Recognizing the dedication and courage of United States veterans, veterans' organizations, and private citizens who have worked and continue to work to evacuate United States persons and vulnerable Afghans from Afghanistan.

This resolution recognizes the dedication and courage of veterans, veterans' organizations, and private citizens who have worked and continue to work to evacuate U.S. persons and vulnerable Afghans from Afghanistan. The resolution also encourages the Department of State and Department of Defense to work with veterans' service organizations and their networks to evacuate those who remain in Afghanistan.

In committee Oct 25, 2021 1 co-sponsor
Co-sponsor HRES 352
In committee Oct 19, 2021 1 co-sponsor
Co-sponsor HR 19
In committee · Utah House · Co-sponsor
Lower Costs, More Cures Act of 2021

Lower Costs, More Cures Act of 2021 This bill establishes and modifies several programs and requirements to address prescription drug prices. The bill modifies provisions under Medicare and Medicaid relating to prescription drug coverage and price transparency. Among other changes, the bill requires the Centers for Medicare & Medicaid Services to publish certain information, as reported by pharmacy benefit managers (PBMs), relating to generic dispensing rates, drug discounts and rebates, and payments between PBMs, health plans, and pharmacies; caps annual out-of-pocket spending under the Medicare prescription drug benefit; allows prescription drug plan sponsors under the Medicare prescription drug benefit to offer additional plans in a region; requires pass-through pricing models, and prohibits spread-pricing, for payment arrangements with PBMs under Medicaid; and allows states to include in the Medicaid Drug Rebate Program covered outpatient drugs that are provided as part of physician or outpatient hospital services. The bill also generally modifies other provisions relating to the regulation and costs of generic and brand-name drugs. Among other changes, the bill prohibits the manufacturer of a brand-name, generic, or biosimilar drug from entering into certain agreements to resolve or settle a patent infringement claim in connection with the sale of a drug or biological product; permanently allows high deductible health plans to waive deductibles for insulin and associated products; and establishes the position of Chief Pharmaceutical Negotiator in the Office of the U.S. Trade Representative.

In committee Oct 19, 2021 1 co-sponsor
Co-sponsor HR 2718
In committee · Utah House · Co-sponsor
Maximum Pressure Act

Maximum Pressure Act This bill expands sanctions and economic penalties on Iran. It also restricts the President from unilaterally lifting or waiving the sanctions or penalties and increases congressional oversight of them. Specifically, the bill requires the President to impose visa- and asset-blocking sanctions. Additionally, it modifies existing sanctions, including by (1) providing statutory authority for executive orders imposing sanctions; (2) applying sanctions to additional sectors of Iran's economy; and (3) broadening sanctionable conduct to cover, for example, assisting Iran with the acquisition of ballistic missiles and the complicity of Iranian officials in human rights violations in specified countries. The bill also requires reporting on licenses that authorize activities subject to sanctions. The bill prohibits U.S. representatives at the International Monetary Fund from voting to allow Iran's access to special drawing rights (a currency support tool) and places restrictions on financial transactions with Iran. The restrictions include requiring domestic financial institutions to implement special measures with respect to foreign financial institutions that conduct significant transactions connected to the Instrument in Support of Trade Exchanges (a European mechanism that bypasses U.S. sanctions when carrying out trade with Iran). The Department of State must maintain the Islamic Revolutionary Guard Corps' designation as a terrorist organization and must designate Ansharallah (or Houthis), which operates in Syria, as a foreign terrorist organization. The bill also requires reports on U.S. sanctions concerning Iran, the status of Iran's nuclear weapons program, and other matters.

In committee Oct 19, 2021 1 co-sponsor
Co-sponsor HR 2579
In committee · Utah House · Co-sponsor
EXIT Act of 2021

Eradicate Crossing of Illegal Tunnels Act of 2021 or the EXIT Act of 2021 This bill authorizes the Department of Homeland Security (DHS) to take various actions to facilitate the search for and remediation of unlawful border crossing tunnels on private land. Specifically, DHS may waive federal, state, or local environmental permits and reviews as necessary to search for or remediate such tunnels. U.S. Customs and Border Protection and U.S. Immigration and Customs Enforcement may enter into indefinite delivery, indefinite quantity contracts with two or more sources to facilitate such border tunnel activities. (Indefinite delivery, indefinite quantity contracts provide for an indefinite quantity of services for a fixed time.)

In committee Oct 19, 2021 1 co-sponsor
Co-sponsor HR 2209
In committee · Utah House · Co-sponsor
Stopping Overdoses of Fentanyl Analogues Act

Stopping Overdoses of Fentanyl Analogues Act This bill adds five fentanyl analogues and the entire category of fentanyl-related substances to schedule I of the Controlled Substances Act. A schedule I controlled substance is a drug, substance, or chemical that has a high potential for abuse; has no currently accepted medical value; and is subject to regulatory controls and administrative, civil, and criminal penalties under the Controlled Substances Act.

In committee Oct 19, 2021 1 co-sponsor
Co-sponsor HR 5598
In committee · Utah House · Co-sponsor
Access to Small Business Investor Capital Act

Access to Small Business Investor Capital Act This bill allows a registered investment company to exclude from the calculation of acquired fund fees and expenses those incurred indirectly from investment in a business development company. Instead, such fees and expenses may be disclosed in a footnote. Acquired fund fees and expenses is a required line item on a fund's fee schedule that provides the operating expenses of the fund.

In committee Oct 15, 2021 1 co-sponsor
Co-sponsor HR 5580
In committee · Utah House · Co-sponsor
Countering China Economic Coercion Act

Countering China Economic Coercion Act This bill establishes an interagency task force to respond to the Chinese government's acts of economic coercion. The task force must oversee the development and implementation of an integrated U.S. government strategy to respond to such acts of economic coercion. The strategy must include an evaluation of the costs such acts have on U.S. businesses and economic performance. The task force must also report to Congress on the strategy as well as a comprehensive review on the economic tools that the Chinese government uses (or can use) to coerce other governments, non-Chinese companies, and multilateral institutions and organizations.

In committee Oct 15, 2021 1 co-sponsor
Co-sponsor HR 5586
In committee · Utah House · Co-sponsor
Prohibiting IRS Financial Surveillance Act

Prohibiting IRS Financial Surveillance Act This bill prohibits the Department of the Treasury from requiring a financial institution to report the transfers into and out of a financial account. This prohibition does not apply to laws or regulations in effect on October 1, 2021.

In committee Oct 15, 2021 1 co-sponsor
Co-sponsor HRES 701
In committee · Utah House · Co-sponsor
Requesting the President, and directing the Secretary of State, to transmit to the House of Representatives copies of all documents in their possession referring or relating to certain aspects of the United States withdrawal from Afghanistan.

This resolution requests the President and directs the Department of State to transmit to the House of Representatives, not later than 14 days after the adoption of this resolution, copies of both classified and unclassified documents that refer or relate to certain information on the withdrawal of the United States from Afghanistan, including reactions, concerns, or objections expressed by certain allies and partners; any agreement reached with the Taliban related to the evacuation of specified individuals; and numbers of specified individuals in contact with the State Department to request evacuation assistance from Afghanistan, from July 30, 2021, to the present.

In committee Oct 5, 2021 1 co-sponsor
Showing 511 to 520 of 664 bills
Previous 1 51 52 53 67 Next